Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.86 | 0.86 | 0.00 |
Stocks | 99.06 | 99.06 | 0.00 |
Other | 0.08 | 0.08 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.88 | 28.10 |
Price to Book | 7.19 | 6.67 |
Price to Sales | 4.32 | 4.19 |
Price to Cash Flow | 19.89 | 18.62 |
Dividend Yield | 0.52 | 0.71 |
5 Years Earnings Growth | 16.02 | 14.91 |
Name | Net % | Category Average |
---|---|---|
Technology | 41.95 | 38.72 |
Consumer Cyclical | 12.58 | 14.13 |
Communication Services | 12.32 | 11.12 |
Healthcare | 11.73 | 12.82 |
Industrials | 9.91 | 7.23 |
Financial Services | 8.70 | 9.28 |
Energy | 1.81 | 1.83 |
Consumer Defensive | 1.01 | 3.79 |
Number of long holdings: 75
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 9.75 | - | - | |
NVIDIA Corp | - | 7.59 | - | - | |
Amazon.com Inc | - | 6.18 | - | - | |
Meta Platforms Inc Class A | - | 5.51 | - | - | |
Apple Inc | - | 5.19 | - | - | |
Alphabet Inc Class C | - | 3.70 | - | - | |
Mastercard Inc Class A | - | 3.05 | - | - | |
Broadcom Inc | - | 2.65 | - | - | |
Eli Lilly and Co | - | 2.55 | - | - | |
Regeneron Pharmaceuticals Inc | - | 1.91 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPMorgan Large Cap Growth R6 | 57.43B | 10.57 | 7.60 | 17.18 | ||
JPMorgan Equity Income R6 | 22.66B | 3.98 | 5.67 | 9.62 | ||
JPMorgan Large Cap Growth Select | 21.38B | 10.48 | 7.33 | 16.87 | ||
JPMorgan Equity Income Select | 16.72B | 3.94 | 5.42 | 9.34 | ||
JPMorgan US Equity R6 | 16.26B | 6.63 | 8.17 | 13.14 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review